Literature DB >> 25582240

The future of red blood cell alloimmunization risk reduction.

Seema Kacker1, Paul M Ness, R Sue Shirey, William J Savage, Karen E King, Aaron A R Tobian.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25582240      PMCID: PMC4739819          DOI: 10.1111/trf.12866

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  7 in total

Review 1.  Cost-effectiveness analysis: what it really means for transfusion medicine decision making.

Authors:  Brian Custer; Jeffrey S Hoch
Journal:  Transfus Med Rev       Date:  2009-01

2.  Wrapping our arms around the cost of transfusion therapy.

Authors:  James R Stubbs
Journal:  Transfusion       Date:  2014-02       Impact factor: 3.157

3.  Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Authors:  E P Vichinsky; N L Luban; E Wright; N Olivieri; C Driscoll; C H Pegelow; R J Adams
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

4.  A delayed transfusion reaction caused by anti-K6.

Authors:  S J Taddie; C Barrasso; P M Ness
Journal:  Transfusion       Date:  1982 Jan-Feb       Impact factor: 3.157

5.  Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2014-02-27       Impact factor: 3.157

6.  Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.

Authors:  Seema Kacker; Paul M Ness; William J Savage; Kevin D Frick; R Sue Shirey; Karen E King; Aaron A R Tobian
Journal:  Transfusion       Date:  2013-05-21       Impact factor: 3.157

7.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

  7 in total
  3 in total

Review 1.  Red Cell Transfusions in the Genomics Era.

Authors:  Jamal H Carter; Willy A Flegel
Journal:  Semin Hematol       Date:  2019-11-08       Impact factor: 3.851

2.  Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

Authors:  Sandhya R Panch; Bipin N Savani; David F Stroncek
Journal:  Semin Hematol       Date:  2019-10       Impact factor: 3.851

3.  Phenotype Frequencies of Major Blood Group Systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) Among Blood Donors in the Eastern Region of Saudi Arabia.

Authors:  Amani Y Owaidah; Noor M Naffaa; Arwa Alumran; Faisal Alzahrani
Journal:  J Blood Med       Date:  2020-02-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.